Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT07444580

PrP-targeting siRNA Safety & Mechanism Study

Led by Broad Institute of MIT and Harvard · Updated on 2026-05-11

30

Participants Needed

4

Research Sites

175 weeks

Total Duration

On this page

Sponsors

B

Broad Institute of MIT and Harvard

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this trial is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic impact of PrP-siRNA in symptomatic prion disease patients.

CONDITIONS

Official Title

PrP-targeting siRNA Safety & Mechanism Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinically manifested symptoms of prion disease as judged by the investigator
  • Diagnosis of probable prion disease according to CDC criteria
  • Positive cerebrospinal fluid RT-QuIC or PRNP genetic test
  • No more than moderate functional impairment with an MRC-PDRS score of 15 or higher
  • Availability of a study partner to assist with study procedures
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Contraindication to lumbar puncture (LP)
  • Recent participation in a different prion disease clinical trial
  • Additional inclusion and exclusion criteria will be evaluated at screening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

2

Mayo Clinic

Rochester, Minnesota, United States, 55905

Actively Recruiting

3

Columbia University Medical Center

New York, New York, United States, 10032

Actively Recruiting

4

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232

Actively Recruiting

Loading map...

Research Team

B

Broad Institute

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here